Related Experiment Video
Updated: Jul 11, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Trichosporon inkin fungemia case report: clinical and laboratory management
Franz Ag Santos1, Melyna C Leite-Andrade1, Maria Ara Vasconcelos2
1Federal University of Pernambuco, Recife, Pernambuco, 50670-901, Brazil.
Abstract:
Trichosporon species are emerging as opportunistic pathogens that mainly affect immunocompromised patients. Patients with onco-hematological diseases usually present with fungemia by Trichosporon species, especially by T. asahii. Reports of this infection by other species of the genus are uncommon. Thus, in this paper, we present a case of T. inkin fungemia in a 39-year-old female patient with intestinal obstruction and absence of malignant hematological diseases. The late mycological diagnosis, the ineffective control of her pre-existing conditions and consequent failure to start antifungal therapy were the contributing factors for the patient's death.
Insights
This study reports a rare case of Trichosporon inkin fungemia in a patient without hematological diseases. Delayed diagnosis and treatment contributed to the fatal outcome, highlighting the need for vigilance against unusual fungal infections.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Clinical Case Study
Background:
- Trichosporon species are opportunistic pathogens, frequently causing fungemia in immunocompromised individuals, particularly those with onco-hematological diseases.
- Trichosporon asahii is the most common species implicated in fungemia, while infections by other Trichosporon species are less frequently reported.
Observation:
- This paper details a rare case of Trichosporon inkin fungemia in a 39-year-old female patient presenting with intestinal obstruction.
- The patient had no underlying malignant hematological diseases, a demographic typically associated with Trichosporon fungemia.
Findings:
- Late mycological diagnosis hindered timely intervention.
- Ineffective management of the patient's pre-existing intestinal obstruction and delayed initiation of antifungal therapy were critical factors.
- These delays ultimately contributed to the patient's mortality.
Implications:
- This case underscores the importance of considering rare fungal pathogens like Trichosporon inkin in the differential diagnosis of fungemia, even in non-immunocompromised patients.
- It highlights the critical role of prompt diagnosis and management of underlying conditions in improving outcomes for invasive fungal infections.
- The findings emphasize the need for broader diagnostic awareness and timely antifungal treatment protocols for invasive Trichosporon infections.
Related Concept Videos
Endocarditis III: Medical Management
Fungal Phylum Microsporidia
Cryptococcal Meningitis
Candidiasis
Trichomoniasis
Antifungal Agents

